Clinical trial
Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular…
NCT00278265 · German CLL Study Group, Other · Terminated
Key facts
| NCT number | NCT00278265 |
|---|---|
| Title | Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia |
| Official title | First Line Therapy With Methotrexate (MTX) and Second Line Therapy With Fludarabine of Patients With T-Cell Large Granular Lymphocyte Leukemia (T-LGL) |
| Lead sponsor | German CLL Study Group, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | T-Cell Large Granular Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | MTX followed by fludarabine |
| Enrollment | 12 |
| Start date | Jun 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jan 18, 2006 |
| Last update posted | Oct 3, 2016 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: